IZURSUM Trademark

Trademark Overview

On Friday, January 5, 2018, a trademark application was filed for IZURSUM with the United States Patent and Trademark Office. The USPTO has given the IZURSUM trademark a serial number of 87744623. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 21, 2022. This trademark is owned by Bristol-Myers Squibb Company. The IZURSUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
izursum

General Information

Serial Number87744623
Word MarkIZURSUM
Filing DateFriday, January 5, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 18, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, March 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 17, 2021SOU EXTENSION 5 GRANTED
Wednesday, August 11, 2021SOU EXTENSION 5 FILED
Tuesday, August 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 11, 2021SOU TEAS EXTENSION RECEIVED
Friday, February 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021SOU EXTENSION 4 GRANTED
Wednesday, February 3, 2021SOU EXTENSION 4 FILED
Wednesday, February 3, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020SOU EXTENSION 3 GRANTED
Wednesday, August 12, 2020SOU EXTENSION 3 FILED
Wednesday, August 12, 2020SOU TEAS EXTENSION RECEIVED
Thursday, February 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 4, 2020SOU EXTENSION 2 GRANTED
Tuesday, February 4, 2020SOU EXTENSION 2 FILED
Tuesday, February 4, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2019SOU EXTENSION 1 GRANTED
Monday, August 12, 2019SOU EXTENSION 1 FILED
Monday, August 12, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, February 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 9, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 9, 2018ASSIGNED TO LIE
Thursday, October 25, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 23, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 23, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 23, 2018NON-FINAL ACTION E-MAILED
Monday, April 23, 2018NON-FINAL ACTION WRITTEN
Monday, April 16, 2018ASSIGNED TO EXAMINER
Friday, January 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 9, 2018NEW APPLICATION ENTERED

Related Keywords

izursum diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection